Cargando…

Combination effects of capecitabine, irinotecan and 17-AAG on colorectal cancer cell line (HT-29)

OBJEVTIVE: Evasion of apoptosis is a major feature of cancer cells, therefore designing treatment strategies to target apoptotic pathways seems effective. In this study, we investigate the effect of 17-AAG (17-allylaminogeldanamycin) alone and in double and triple combination with capecitabine (Cap)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeynali-Moghaddam, Shima, Kheradmand, Fatemeh, Gholizadeh-Ghaleh Aziz, Shiva, Abroon, Sina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Experimental Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207062/ https://www.ncbi.nlm.nih.gov/pubmed/35734719 http://dx.doi.org/10.1016/j.amsu.2022.103850

Ejemplares similares

Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines
por: Mohammadian, Mahshid, et al.
Publicado: (2017)

Dihydropyrimidine Dehydrogenase Levels in Colorectal Cancer Cells Treated with a Combination of Heat Shock Protein 90 Inhibitor and Oxaliplatin or Capecitabine
por: Mohammadian, Mahshid, et al.
Publicado: (2019)

The human amniotic fluid mesenchymal stem cells therapy on, SKOV3, ovarian cancer cell line
por: Gholizadeh‐Ghaleh Aziz, Shiva, et al.
Publicado: (2019)

Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer
por: Wilbur, H. Catherine, et al.
Publicado: (2023)

Alantolactone and ZnO nanoparticles induce apoptosis activity of cisplatin in an ovarian cancer cell line (SKOV3)
por: Alipour, Shahriar, et al.
Publicado: (2022)

Development of phimosis as an adverse drug reaction to capecitabine with irinotecan
por: Patel, Priyeshkumar, et al.
Publicado: (2022)

Imatinib and its combination with 2,5-dimethyl-celecoxibinduces apoptosis of human HT-29 colorectal cancer cells
por: Atari-Hajipirloo, Somayeh, et al.
Publicado: (2017)

Evaluating the effect of Alantolactone on the expression of N-cadherin and Vimentin genes effective in epithelial-mesenchymal transition (EMT) in breast cancer cell line (MDA-MB-231)
por: Naderi, Roya, et al.
Publicado: (2022)

Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer
por: García-Alfonso, P, et al.
Publicado: (2010)

Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21)
por: Amini, Afshin, et al.
Publicado: (2013)

Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer
por: Yip, Pui Lam, et al.
Publicado: (2023)

Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Chong, G, et al.
Publicado: (2005)

17AAG-induced internalisation of HER2-specific Affibody molecules
por: Göstring, Lovisa, et al.
Publicado: (2016)

Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines
por: Bang, Yeong Hak, et al.
Publicado: (2021)

17-AAG Induces Cytoplasmic α-Synuclein Aggregate Clearance by Induction of Autophagy
por: Riedel, Michael, et al.
Publicado: (2010)

Effects of salinomycin and 17-AAG on proliferation of human gastric cancer cells in vitro
por: Zhang, Zuwen, et al.
Publicado: (2017)

17-AAG-Induced Activation of the Autophagic Pathway in Leishmania Is Associated with Parasite Death
por: Petersen, Antonio Luis de O. A., et al.
Publicado: (2021)

Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
por: Lee, Sung Uk, et al.
Publicado: (2013)

A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
por: Vasile, E, et al.
Publicado: (2009)

Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer
por: Bazarbashi, Shouki, et al.
Publicado: (2015)

Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Alliot, C
Publicado: (2006)

Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in transgenic mouse models of frontotemporal lobar degeneration and Alzheimer’s disease
por: Ho, Shuk Wai, et al.
Publicado: (2013)

Chemotherapeutic Potential of 17-AAG against Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis
por: Santos, Diego M., et al.
Publicado: (2014)

Effects of 17-AAG on the cell cycle and apoptosis of H446 cells and the associated mechanisms
por: Zhao, Xuerong, et al.
Publicado: (2016)

Nobelprismodtager Aage Bohr er død
Publicado: (2009)

Nobelpristageren Aage Bohr er død
Publicado: (2009)

Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer
por: Baek, J H, et al.
Publicado: (2006)

Reply: Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Chong, G, et al.
Publicado: (2006)

Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
por: Li, Wenhua, et al.
Publicado: (2014)

17-AAG Kills Intracellular Leishmania amazonensis while Reducing Inflammatory Responses in Infected Macrophages
por: Petersen, Antonio Luis de Oliveira Almeida, et al.
Publicado: (2012)

Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines
por: Gheytanchi, Elmira, et al.
Publicado: (2021)

Isolation, Characterization, Cryopreservation of Human Amniotic Stem Cells and Differentiation to Osteogenic and Adipogenic Cells
por: Gholizadeh-Ghaleh Aziz, Shiva, et al.
Publicado: (2016)

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis
por: Zarate, R, et al.
Publicado: (2010)

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer
por: Suenaga, Mitsukuni, et al.
Publicado: (2015)

In Vitro Study of Influence of Au Nanoparticles on HT29 and SPEV Cell Lines
por: Pavlovich, Elena, et al.
Publicado: (2017)

Carvacrol alters soluble factors in HCT-116 and HT-29 cell lines
por: PAKDEMİRLİ, Ahu, et al.
Publicado: (2020)

Biweekly cetuximab in combination with capecitabine and oxaliplatin (XELOX) or irinotecan (XELIRI) in the first-line and second-line treatment of patients with RAS wild-type metastatic colorectal cancer
por: Zekri, Jamal, et al.
Publicado: (2022)

A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma
por: Burge, M E, et al.
Publicado: (2006)

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study
por: Garcia-Alfonso, Pilar, et al.
Publicado: (2015)

Pauli letter collection: letter to Aage Bohr
por: Pauli, Wolfgang
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_fr5fne2u6lpq6reit0jf4fgibk